Health

Biotech News Roundup: Novo Nordisk and PhRMA Developments

Updated 2026-05-06 13:45 UTC 1 source Neutral

Novo Nordisk's earnings were boosted by positive news on its Wegovy pill. Meanwhile, the powerful pharmaceutical lobbying group PhRMA is launching a new advertising campaign targeting a federal drug discount program.

Coverage timeline — 2 articles

STAT News

STAT+: Pharmalittle: We’re reading about a PhRMA ad campaign aimed at 340B, sales of Novo’s obesity pill, and more

One of the most powerful pharmaceutical lobbying groups is launching a new seven-figure advertising blitz targeting a federal drug discount program

2026-05-06 13:34 UTC

STAT News

STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share price

Vivek Ramaswamy wins GOP primary for Ohio governor, CellCentric raises $220M for myeloma drug, and more biotech news

2026-05-06 13:34 UTC